A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo – A substudy for IBIS I Breast Cancer Prevention Trial
Alaotsikko: A substudy for IBIS I Breast Cancer Prevention Trial
Tekijät: Palva T, Ranta H, Koivisto AM, Pylkkänen L, Cuzick J, Holli K
Kustantaja: ELSEVIER SCI LTD
Julkaisuvuosi: 2013
Journal: European Journal of Cancer
Tietokannassa oleva lehden nimi: EUROPEAN JOURNAL OF CANCER
Lehden akronyymi: EUR J CANCER
Numero sarjassa: 1
Vuosikerta: 49
Numero: 1
Aloitussivu: 45
Lopetussivu: 51
Sivujen määrä: 7
ISSN: 0959-8049
DOI: https://doi.org/10.1016/j.ejca.2012.06.015
Tiivistelmä
Conclusions: The discontinuation rate in the TAM group was high, and the discontinuations also occurred early. Even though there were significantly more non-serious gynaecological events during the TAM treatment, routine gynaecological follow-up cannot be recommended. (C) 2012 Elsevier Ltd. All rights reserved.
Conclusions: The discontinuation rate in the TAM group was high, and the discontinuations also occurred early. Even though there were significantly more non-serious gynaecological events during the TAM treatment, routine gynaecological follow-up cannot be recommended. (C) 2012 Elsevier Ltd. All rights reserved.
Turun yliopiston Tutkimustietojärjestelmän portaali